Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with them first.
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of:
This product...
Read moreAfter intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related... Read more »
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Isn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
A new study indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating osteoporosis in postmenopausal... Read more »
Q. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
A Food and Drug Administration (FDA) panel has recommended Evista for use in preventing breast cancer. Evista is an osteoporosis medication that has... Read more »
Doctors at the University of Minnesota have found that the osteoporosis drug Evista is safe and effective in women with mild to moderate chronic... Read more »
The Food and Drug Administration has approved the osteoporosis med Evista for use in reducing the risk of breast cancer. Evista is approved to treat... Read more »
The U.S. Food and Drug Administration has granted tentative approval for a generic form of the commonly used osteoporosis drug Evista. However, the... Read more »
Source: Breastcancer.org
Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of... Read more »